Epicrispr Biotechnologies vs Freenome
Epicrispr Biotechnologies vs Freenome, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and Freenome on 59/100.
Where each one leads
Epicrispr Biotechnologies
Leads on none of the measures we hold for both companies.
Freenome
- agent readiness: 46/100 against 39/100
- domain rating: 56/100 against 40/100
- headcount: 402 against 51
- funding raised: $570M against $90.0M
- LinkedIn following: 46,860 against 7,025
At a glance
| Measure | Epicrispr Biotechnologies | Freenome |
|---|---|---|
| What it is | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). | Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology. |
| Category | Biotechnology, Therapeutics, Rare Diseases, Epigenetics | Biotechnology, Healthcare, Artificial Intelligence, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2020 | 2014 |
| Headquarters | South San Francisco, United States | South San Francisco, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Epicrispr Biotechnologies | Freenome |
|---|---|---|
| Employees | 51 | 402 |
| Total funding | $90.0M | $570M |
| Latest round | Series C | Series D |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 7,025 | 46,860 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epicrispr Biotechnologies | Freenome |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 59/100 |
| Traction | 57/100 | 60/100 |
| Team | 40/100 | Not published |
| Search visibility | 20/100 | 31/100 |
| Quality | 78/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (46/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 56/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epicrispr Biotechnologies | Freenome |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Jquery |
| Analytics | Google Analytics 4 | Google Tag Manager |
| Support stack | Not detected | HubSpot |
Epicrispr Biotechnologies vs Freenome: common questions
Which is better, Epicrispr Biotechnologies or Freenome?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 59/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Epicrispr Biotechnologies and Freenome compare on the numbers?
Freenome leads on agent readiness (46/100 against 39/100), domain rating (56/100 against 40/100), headcount (402 against 51), funding raised ($570M against $90.0M), LinkedIn following (46,860 against 7,025).
Read the full Epicrispr Biotechnologies review and pricing or the Freenome review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.